129 related articles for article (PubMed ID: 10908120)
1. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
[No Abstract] [Full Text] [Related]
2. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
[No Abstract] [Full Text] [Related]
4. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
[TBL] [Abstract][Full Text] [Related]
5. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
Block C; Robenshtok E; Simhon A; Shapiro M
J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
[TBL] [Abstract][Full Text] [Related]
8. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
[TBL] [Abstract][Full Text] [Related]
9. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Nomura S; Hanaki H; Unemi N
Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
[TBL] [Abstract][Full Text] [Related]
11. Novel cephalosporins. Modification of the C-4 carboxyl group.
Jen T; Dienel B; Frazee J; Weisbach J
J Med Chem; 1972 Nov; 15(11):1172-4. PubMed ID: 4631921
[No Abstract] [Full Text] [Related]
12. Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus.
Hanaki H; Akagi H; Yasui M; Otani T
J Antibiot (Tokyo); 1995 Aug; 48(8):901-3. PubMed ID: 7592041
[No Abstract] [Full Text] [Related]
13. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
Ishikawa T; Kamiyama K; Matsunaga N; Tawada H; Iizawa Y; Okonogi K; Miyake A
J Antibiot (Tokyo); 2000 Oct; 53(10):1071-85. PubMed ID: 11132951
[TBL] [Abstract][Full Text] [Related]
14. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
[No Abstract] [Full Text] [Related]
16. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
17. Polymicrobial endocarditis caused by methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococci.
Bishara J; Sagie A; Samra Z; Pitlik S
Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):674-5. PubMed ID: 10534195
[No Abstract] [Full Text] [Related]
18. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3.
Ishikawa T; Kamiyama K; Nakayama Y; Iizawa Y; Okonogi K; Miyake A
J Antibiot (Tokyo); 2001 Mar; 54(3):257-77. PubMed ID: 11372783
[TBL] [Abstract][Full Text] [Related]
19. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
Springer DM; Luh BY; Bronson JJ
Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
Lozniewski A; Lion C; Mory F; Weber M
J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
